US releases experimental Ebola drug for DR Congo outbreak trials

The US is sending experimental Ebola drugs to the Democratic Republic of Congo as part of clinical trials amid a rapidly expanding outbreak that has already claimed over 250 lives from more than 1,000 cases. This move underscores the urgency and gravity of the situation, highlighting the global health community's efforts to combat the outbreak. With the World Health Organization and US officials involved, the trial aims to assess the effectiveness of these experimental treatments, potentially offering a lifeline in the fight against this deadly virus.